These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 29729697)

  • 1. RASSF7 promotes cell proliferation through activating MEK1/2-ERK1/2 signaling pathway in hepatocellular carcinoma.
    Zhang M; Li Q; Zhang L; Wang Y; Wang L; Li Q; He T; Wan B; Wang X
    Cell Mol Biol (Noisy-le-grand); 2018 Apr; 64(5):73-79. PubMed ID: 29729697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. lncRNA DRHC inhibits proliferation and invasion in hepatocellular carcinoma via c-Myb-regulated MEK/ERK signaling.
    Zhuang R; Zhang X; Lu D; Wang J; Zhuo J; Wei X; Ling Q; Xie H; Zheng S; Xu X
    Mol Carcinog; 2019 Mar; 58(3):366-375. PubMed ID: 30362626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing of CDCA5 inhibits cancer progression and serves as a prognostic biomarker for hepatocellular carcinoma.
    Wang J; Xia C; Pu M; Dai B; Yang X; Shang R; Yang Z; Zhang R; Tao K; Dou K
    Oncol Rep; 2018 Oct; 40(4):1875-1884. PubMed ID: 30015982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNAi-mediated MEK1 knock-down prevents ERK1/2 activation and abolishes human hepatocarcinoma growth in vitro and in vivo.
    Gailhouste L; Ezan F; Bessard A; Frémin C; Rageul J; Langouët S; Baffet G
    Int J Cancer; 2010 Mar; 126(6):1367-77. PubMed ID: 19816936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ERK pathway activation contributes to the tumor-promoting effects of hepatic stellate cells in hepatocellular carcinoma.
    Xie YX; Liao R; Pan L; Du CY
    Immunol Lett; 2017 Aug; 188():116-123. PubMed ID: 28668554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of metastasis-associated in colon cancer 1 inhibition by small hairpin RNA on ovarian carcinoma OVCAR-3 cells.
    Zhang R; Shi H; Chen Z; Wu Q; Ren F; Huang H
    J Exp Clin Cancer Res; 2011 Sep; 30(1):83. PubMed ID: 21923915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
    Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
    Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rap2B knockdown suppresses malignant progression of hepatocellular carcinoma by inactivating the PTEN/PI3K/Akt and ERK1/2 pathways.
    Zhu L; Sun Y; Zhang S; Wang L
    Mol Cell Biochem; 2020 Mar; 466(1-2):55-63. PubMed ID: 32052247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MEK1/2 overactivation can promote growth arrest by mediating ERK1/2-dependent phosphorylation of p70S6K.
    Guégan JP; Ezan F; Gailhouste L; Langouët S; Baffet G
    J Cell Physiol; 2014 Jul; 229(7):903-15. PubMed ID: 24501087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposome-mediated RNA interference delivery against Erk1 and Erk2 does not equally promote chemosensitivity in human hepatocellular carcinoma cell line HepG2.
    Mehdizadeh A; Somi MH; Darabi M; Farajnia S; Akbarzadeh A; Montazersaheb S; Yousefi M; Bonyadi M
    Artif Cells Nanomed Biotechnol; 2017 Dec; 45(8):1612-1619. PubMed ID: 28058860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA‑125a‑5p controls the proliferation, apoptosis, migration and PTEN/MEK1/2/ERK1/2 signaling pathway in MCF‑7 breast cancer cells.
    Liang Z; Pan Q; Zhang Z; Huang C; Yan Z; Zhang Y; Li J
    Mol Med Rep; 2019 Nov; 20(5):4507-4514. PubMed ID: 31702027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic silencing of PRSS3 provides growth and metastasis advantage for human hepatocellular carcinoma.
    Lin B; Zhou X; Lin S; Wang X; Zhang M; Cao B; Dong Y; Yang S; Wang JM; Guo M; Huang J
    J Mol Med (Berl); 2017 Nov; 95(11):1237-1249. PubMed ID: 28844099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA UBE2CP3 enhances HCC cell secretion of VEGFA and promotes angiogenesis by activating ERK1/2/HIF-1α/VEGFA signalling in hepatocellular carcinoma.
    Lin J; Cao S; Wang Y; Hu Y; Liu H; Li J; Chen J; Li P; Liu J; Wang Q; Zheng L
    J Exp Clin Cancer Res; 2018 Jun; 37(1):113. PubMed ID: 29866133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ERK1/2 activation mediated by the nutlin‑3‑induced mitochondrial translocation of p53.
    Lee SY; Shin SJ; Kim HS
    Int J Oncol; 2013 Mar; 42(3):1027-35. PubMed ID: 23314357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SIRT6 regulates the proliferation and apoptosis of hepatocellular carcinoma via the ERK1/2 signaling pathway.
    Zhang C; Yu Y; Huang Q; Tang K
    Mol Med Rep; 2019 Aug; 20(2):1575-1582. PubMed ID: 31257493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.
    Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C
    Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of CXCL2 inhibits cell proliferation and promotes apoptosis in hepatocellular carcinoma.
    Ding J; Xu K; Zhang J; Lin B; Wang Y; Yin S; Xie H; Zhou L; Zheng S
    BMB Rep; 2018 Dec; 51(12):630-635. PubMed ID: 30293547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MECP2 promotes cell proliferation by activating ERK1/2 and inhibiting p38 activity in human hepatocellular carcinoma HEPG2 cells.
    Zhao LY; Zhang J; Guo B; Yang J; Han J; Zhao XG; Wang XF; Liu LY; Li ZF; Song TS; Huang C
    Cell Mol Biol (Noisy-le-grand); 2013 Nov; Suppl 59():OL1876-81. PubMed ID: 24199952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRIM52 up-regulation in hepatocellular carcinoma cells promotes proliferation, migration and invasion through the ubiquitination of PPM1A.
    Zhang Y; Tao R; Wu SS; Xu CC; Wang JL; Chen J; Yu YS; Tang ZH; Chen XH; Zang GQ
    J Exp Clin Cancer Res; 2018 Jun; 37(1):116. PubMed ID: 29898761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of castor zinc finger 1 predicts poor prognosis and facilitates hepatocellular carcinoma progression via MAPK/ERK signaling.
    Wang JL; Yang MY; Xiao S; Sun B; Li YM; Yang LY
    J Exp Clin Cancer Res; 2018 Mar; 37(1):45. PubMed ID: 29506567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.